(Q45024872)

8 December 2017

title

Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma (English)

1 reference

8 December 2017

Shuang Wang

1

1 reference

8 December 2017

Weiyi Fang

series ordinal

2

1 reference

8 December 2017

publication date

24 January 2011

1 reference

8 December 2017

1 reference

8 December 2017

volume

58

1 reference

8 December 2017

issue

2

1 reference

8 December 2017

page(s)

217-224

1 reference

Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Nasopharyngeal carcinoma: molecular biomarker discovery and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Partial purification and characterization of human hepatoma-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

An endothelial growth factor involved in rat renal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Fetal lung development: airway pressure enhances the expression of developmental genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Hepatoma-derived growth factor is expressed after vascular injury in the rat and stimulates smooth muscle cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Expression of hepatoma-derived growth factor in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Hepatoma derived growth factor is a nuclear targeted mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2010.03739.X

10.1111/J.1365-2559.2010.03739.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference